| Eri Haruko Shimizu, MD | |
|
270 Hookahi Street, Suite 305, Wailuku, HI 96793 | |
| (808) 435-6262 | |
| (877) 795-4940 |
| Full Name | Eri Haruko Shimizu |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 270 Hookahi Street, Wailuku, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063678456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 15871 (Hawaii) | Secondary |
| 208M00000X | Hospitalist | MD-15871 (Hawaii) | Secondary |
| 208D00000X | General Practice | 15871 (Hawaii) | Primary |
| Entity Name | Hawaii Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710945969 PECOS PAC ID: 7618880667 Enrollment ID: O20031106000625 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results today from a Phase 1 study comparing a dose-timing strategy of PA32540 and clopidogrel spaced 10 hours apart as compared to synchronous administration of enteric-coated (EC) omeprazole (40 mg), enteric-coated aspirin (81 mg) and clopidogrel.
A new three-state study shows a slight decrease in inpatient procedures for 2.4 million patients treated for lower extremity peripheral arterial disease (PAD) between 1998 and 2007, but reveals gender disparities in emergent hospital admissions and mortality rates for women.
Smoking high potency 'skunk-like' cannabis can damage a crucial part of the brain responsible for communication between the two brain hemispheres, according to a new study by scientists from King's College London and Sapienza University of Rome.
QLT Inc., a company dedicated to the development and commercialization of innovative therapies for the eye, announced today that the company has been added to the Russell Global Index. The 2010 reconstitution of the Russell Indexes, a comprehensive set of U.S. and global equity indexes created by Russell Investments, took place after the market close on June 25, 2010.
› Verified 4 days ago
| Entity Name | Eri Shimizu Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053035584 PECOS PAC ID: 1052787199 Enrollment ID: O20221014001542 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results today from a Phase 1 study comparing a dose-timing strategy of PA32540 and clopidogrel spaced 10 hours apart as compared to synchronous administration of enteric-coated (EC) omeprazole (40 mg), enteric-coated aspirin (81 mg) and clopidogrel.
A new three-state study shows a slight decrease in inpatient procedures for 2.4 million patients treated for lower extremity peripheral arterial disease (PAD) between 1998 and 2007, but reveals gender disparities in emergent hospital admissions and mortality rates for women.
Smoking high potency 'skunk-like' cannabis can damage a crucial part of the brain responsible for communication between the two brain hemispheres, according to a new study by scientists from King's College London and Sapienza University of Rome.
QLT Inc., a company dedicated to the development and commercialization of innovative therapies for the eye, announced today that the company has been added to the Russell Global Index. The 2010 reconstitution of the Russell Indexes, a comprehensive set of U.S. and global equity indexes created by Russell Investments, took place after the market close on June 25, 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eri Haruko Shimizu, MD 115 Kamaiki Circle, Kahului, HI 96732 Ph: (808) 500-8420 | Eri Haruko Shimizu, MD 270 Hookahi Street, Suite 305, Wailuku, HI 96793 Ph: (808) 435-6262 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results today from a Phase 1 study comparing a dose-timing strategy of PA32540 and clopidogrel spaced 10 hours apart as compared to synchronous administration of enteric-coated (EC) omeprazole (40 mg), enteric-coated aspirin (81 mg) and clopidogrel.
A new three-state study shows a slight decrease in inpatient procedures for 2.4 million patients treated for lower extremity peripheral arterial disease (PAD) between 1998 and 2007, but reveals gender disparities in emergent hospital admissions and mortality rates for women.
Smoking high potency 'skunk-like' cannabis can damage a crucial part of the brain responsible for communication between the two brain hemispheres, according to a new study by scientists from King's College London and Sapienza University of Rome.
QLT Inc., a company dedicated to the development and commercialization of innovative therapies for the eye, announced today that the company has been added to the Russell Global Index. The 2010 reconstitution of the Russell Indexes, a comprehensive set of U.S. and global equity indexes created by Russell Investments, took place after the market close on June 25, 2010.
› Verified 4 days ago
Deborah Mathias, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 2180 Main St, Wailuku, HI 96793 Phone: 808-242-6464 Fax: 808-243-2343 | |
Karen L. Downard, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 80 Mahalani St, Wailuku, HI 96793 Phone: 808-243-6000 |